Skip to main content

Year: 2025

MTY Reports First Quarter Results for Fiscal 2025

Normalized adjusted EBITDA(1) increased 1% to reach $60.2 million in the quarter, compared to $59.5 million in Q1-24. Franchise segment Normalized adjusted EBITDA(1) rose 1% to attain $44.0 million, or 47% of sales. System sales(2) for the quarter improved by 2.5% or $33.1 million to reach $1,364.8 million compared to $1,331.7 million in Q1-24 primarily due to favourable foreign exchange. Cash flows provided by operating activities were $58.8 million compared to $54.2 million in Q1-24, an increase of $4.6 million mostly due to a decrease in interest paid on long-term debt. Free cash flows net of lease payments(1) increased to $43.5 million in the quarter compared to $36.9 million in Q1-24. Free cash flows net of lease payments per diluted share(3) were $1.87 for the quarter compared to $1.52 in Q1-24. Net income attributable to owners...

Continue reading

Correction: HSBC Bank Plc – Form 8.5 (EPT/RI) – Advanced Medical Solutions Group plc

AmendmentFORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY                                    Rule 8.5 of the Takeover Code (the “Code”)                                                                     1.         KEY INFORMATION(a) Name of exempt principal trader: HSBC Bank Plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates:     Use a separate form for each offeror/offeree Advanced Medical Solutions Group plc(c) Name of the party to the offer with which exempt principal trader is connected: OFFEREE: Advanced Medical Solutions Group plc(d) Date dealing undertaken: 09 April 2025(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures...

Continue reading

On the Resolutions Adopted at the Extraordinary General Meeting of Shareholders and the Election of the Chairman of the Board

Draft resolutions of the Extraordinary General Meeting of Shareholders of PST Group AB held on 11 April 2025 are as follows: 1. On the election of a new Board of the company after the expiry of the term of office of the current Board. To elect members of the Board of PST Group AB:Jurgita Jurkštaitytė (born 1975) – Education: Vytautas Magnus University, Master of Business Law. Participation in activities of other companies: Lawyer, law firm “Jurkštaitytė and Partners”, Member of the Board of AB “HISK”. Justas Jasiūnas (b. 1982) – Education: Mykolas Romeris University, Master’s degree in Law. Participation in activities of other companies: Board member of AB “HISK.” Lina Simaškienė (b. 1968) (as an independent board member) – Education: Kaunas University of Technology, qualification as an Engineer-Economist....

Continue reading

Bilibili Inc. to Hold Annual General Meeting on June 20, 2025

SHANGHAI, April 11, 2025 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today published a circular (the “AGM Circular”) to provide shareholders with information on the proposals that will be put forward at the Company’s annual general meeting of the shareholders (the “AGM”) for shareholders’ approval and a notice of the AGM (the “AGM Notice”). The AGM will be held at Building 3, Guozheng Center, No. 485 Zhengli Road, Yangpu District, Shanghai, People’s Republic of China on June 20, 2025 at 4:30 p.m. (Hong Kong time), to consider and vote on the resolutions set forth in the AGM Notice. The AGM Circular, AGM Notice and form of proxy for the AGM are available on the Company’s investor relations website at http://ir.bilibili.com. Holders...

Continue reading

CIB Marine Bancshares, Inc. Announces First Quarter 2025 Results

BROOKFIELD, Wis., April 11, 2025 (GLOBE NEWSWIRE) — CIB Marine Bancshares, Inc. (the “Company” or “CIB Marine”) (OTCQX: CIBH), the holding company of CIBM Bank (the “Bank”), announced its unaudited results of operations and financial condition for the quarter and three months ended March 31, 2025. Net income of $0.3 million for the first quarter of 2025, or $0.24 basic and $0.23 diluted net income per share, compares to $0.2 million during the same quarter of 2024, or $0.13 basic and $0.10 diluted net income per share. Financial highlights for the quarter include:Net interest margin increased to 2.62% compared to 2.44% for the fourth quarter of 2024 and 2.29% for the first quarter of 2024. The rising trend continues as the cost of funds reprices lower relative to the changes in yields on earning assets. Net interest income rose...

Continue reading

Completion of share split

Company announcementfor ROCKWOOL A/SRelease no. 22 – 2025to Nasdaq Copenhagen         11 April 2025 Completion of share split At the Annual General Meeting of ROCKWOOL A/S (the “Company”) held on 2 April 2025, it was resolved to complete a share split in the ratio of 1:10, whereby each existing share with a nominal value of 10 DKK would be divided into 10 shares with a nominal value of 1 DKK. The share split has now been completed. Following completion of the share split, the Company’s share capital consists of nominally 216,207,090 DKK, divided into 216,207,090 shares with a nominal value of 1 DKK, of which 98,178,390 are A shares and 118,028,700 are B shares. Further information:         Kim Junge AndersenSenior Vice President, CFOROCKWOOL A/S+45 46 55 80 15AttachmentSE-2025-22_EN

Continue reading

Notice to the Annual General Meeting of KH Group Plc

KH Group PlcStock Exchange Release 11 April 2025 at  10:00 am EEST Notice to the Annual General Meeting of KH Group Plc Notice is given to the shareholders of KH Group Plc (“KH Group” or the “Company”) to the Annual General Meeting to be held on Tuesday, 6 May 2025 at 2:00 p.m. EEST at Sanomatalo, Flik Event Studio Eliel, at the address Töölönlahdenkatu 2, 00100 Helsinki, Finland. The reception of attendees who have registered for the meeting and the distribution of voting tickets will commence at 1:30 p.m. EEST. Shareholders may also exercise their voting rights by voting in advance. Shareholders who have registered for the meeting may also follow the meeting via a live webcast. Further instructions for shareholders are provided in section C “Instructions for the participants in the Annual General Meeting” of this notice. In connection...

Continue reading

Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia 

Singapore, April 11, 2025 (GLOBE NEWSWIRE) — Basel Medical Group Ltd (Nasdaq: BMGL), today announced the signing of a definitive agreement by its subsidiary Basel Medical Group Pte. Ltd. to acquire Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare provider specializing in diagnostic imaging and outpatient care. The agreement marks a significant step in Basel Medical Group’s strategic expansion in Singapore and the broader Southeast Asian healthcare market. The completion of the acquisition is subject to customary closing conditions and is expected to take place on or around April 30, 2025 or such other date agreed by the parties. Strategic Partnership Evolves into Full Integration Basel Medical Group and Bethesda Medical have been collaborating on strategic partnerships aimed at enhancing patient care and operational...

Continue reading

SMCP – Kleine TAN appointed as CEO of SMCP Asia

Press Release – Paris, April 11th, 2025 Kleine TAN appointed as CEO of SMCP Asia SMCP Group, parent company of the Sandro, Maje, Claudie Pierlot and Fursac brands, is pleased to announce the appointment of Kleine Tan as CEO of SMCP Asia, effective April 1st, 2025. He succeeds Jimmy Lam who has decided to pursue new opportunities outside the Group. Isabelle Guichot, CEO of SMCP Group, said: “I am very pleased to welcome Kleine Tan as CEO of SMCP Asia. Having lived and worked in Asia for the past two decades, Kleine brings a solid international perspective and a deep understanding of the retail and wholesale dynamics across the Asia-Pacific region. As we continue to implement our strategic roadmap in the region, notably with our network optimization in China, I am confident that Kleine will bring a new pragmatic and expert vision to the...

Continue reading

Publication annual report 2024, convening notice for the General Meeting and proposal new directors

Publication annual report 2024, convening notice for the General Meeting and proposal new directors Regulated information 11 April 2025, 8 am CET Kinepolis Group NV presents its integrated annual report 2024, with a comprehensive overview of the Group’s strategic, financial, operational and ESG performance for the year 2024. The report is available in English and Dutch and can be accessed via this link. Kinepolis’ annual report 2024 is the first report prepared in accordance with the guidelines of the EU’s Corporate Sustainability Reporting Directive (CSRD). It contains information on policies, actions and performance indicators regarding Kinepolis’ sustainability priorities, based on an analysis of current and potential impacts, risks and opportunities. With a clear vision of the future of cinema, Kinepolis is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.